Fig. 1

Anti-Factor Xa levels and total daily enoxaparin dose administered across for the first 14 days of Intensive Care Unit (ICU) admission for standard-dose (a) and intermediate-dose cohorts (b). Doses were adjusted throughout admission at clinicians’ discretion. Day 1 reflects admission day to ICU, therefore depending on the time of admission, patients in the intermediate-dose cohort received either two or only one dose of enoxaparin